FDA ACCOUNTABILITY FOR REVIEW DEADLINES IS SOUGHT IN KASSEBAUM REFORM DRAFT; MISSED DEADLINES WOULD BE INCLUDED IN ANNUAL REPORT TO OVERSIGHT PANEL
Executive Summary
FDA officials would be held accountable for not meeting statutory deadlines for review of new drug applications under the Senate Labor & Human Resources Committee FDA reform concept paper.